{"id":"https://openalex.org/W4396974737","doi":"https://doi.org/10.1016/j.bmcl.2024.129797","title":"Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors","display_name":"Design and synthesis of novel thiazole-derivatives as potent ALK5 inhibitors","publication_year":2024,"publication_date":"2024-05-16","ids":{"openalex":"https://openalex.org/W4396974737","doi":"https://doi.org/10.1016/j.bmcl.2024.129797","pmid":"https://pubmed.ncbi.nlm.nih.gov/38759932"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2024.129797","doi":"https://doi.org/10.1016/j.bmcl.2024.129797","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2024.129797","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079200004","display_name":"Mai Arai","orcid":"https://orcid.org/0009-0001-3317-5347","observed_orcids":["https://orcid.org/0009-0001-3317-5347"]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Mai Arai","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan. Electronic address: mai.arai@dd.carnabio.com","Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":"https://orcid.org/0009-0001-3317-5347","affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan. Electronic address: mai.arai@dd.carnabio.com","institution_ids":["https://openalex.org/I4405285453"]},{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088712195","display_name":"Mitsuharu Hanada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuharu Hanada","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hideki Moriyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideki Moriyama","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Hiroshi Ohmoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Ohmoto","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Takahiro Miyake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takahiro Miyake","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023645919","display_name":"Kazuhito Naka","orcid":"https://orcid.org/0000-0001-6646-6004","observed_orcids":["https://orcid.org/0000-0001-6646-6004"]},"institutions":[{"id":"https://openalex.org/I4405287266","display_name":"Research Institute for Radiation Biology and Medicine, Hiroshima University","ror":"https://ror.org/04mfv5z87","country_code":"JP","type":"facility","lineage":["https://openalex.org/I113306721","https://openalex.org/I4405287266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuhito Naka","raw_affiliation_strings":["Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Stem Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8553, Japan","institution_ids":["https://openalex.org/I4405287266"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011509062","display_name":"Masaaki Sawa","orcid":"https://orcid.org/0000-0002-0077-2188","observed_orcids":["https://orcid.org/0000-0002-0077-2188"]},"institutions":[{"id":"https://openalex.org/I4405285453","display_name":"Carna Biosciences (Japan)","ror":"https://ror.org/05fw9gc86","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405285453"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaaki Sawa","raw_affiliation_strings":["Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan"],"raw_orcid":"https://orcid.org/0000-0002-0077-2188","affiliations":[{"raw_affiliation_string":"Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan","institution_ids":["https://openalex.org/I4405285453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5079200004"],"corresponding_institution_ids":["https://openalex.org/I4405285453"],"apc_list":{"value":3770,"currency":"USD","value_usd":3770},"apc_paid":null,"fwci":0.5497,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.48608205,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":97},"biblio":{"volume":"108","issue":null,"first_page":"129797","last_page":"129797"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5307999849319458,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.5307999849319458,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.40059998631477356,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thiazole-derivatives","display_name":"thiazole derivatives","score":0.984000027179718},{"id":"https://openalex.org/keywords/alk5-inhibitor","display_name":"ALK5 inhibitor","score":0.9869999885559082},{"id":"https://openalex.org/keywords/tgf-beta-signaling","display_name":"TGF-beta signaling","score":0.9380000233650208},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.8050000071525574},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.828000009059906},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9879999756813049},{"id":"https://openalex.org/keywords/kinase-inhibitor-selectivity","display_name":"kinase selectivity","score":0.6489999890327454},{"id":"https://openalex.org/keywords/anticancer-drug-discovery","display_name":"anticancer drug discovery","score":0.5680000185966492}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9199918508529663},{"id":"https://openalex.org/C2778464347","wikidata":"https://www.wikidata.org/wiki/Q413426","display_name":"Thiazole","level":2,"score":0.8225346803665161},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.47302699089050293},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.45641404390335083},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3937467336654663},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.33144044876098633},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23953327536582947},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2071169912815094},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077293","descriptor_name":"Receptor, Transforming Growth Factor-beta Type I","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D000077293","descriptor_name":"Receptor, Transforming Growth Factor-beta Type I","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017346","descriptor_name":"Protein Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018125","descriptor_name":"Receptors, Transforming Growth Factor beta","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018125","descriptor_name":"Receptors, Transforming Growth Factor beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2024.129797","doi":"https://doi.org/10.1016/j.bmcl.2024.129797","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2024.129797","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:38759932","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38759932","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1971730330","https://openalex.org/W2000977869","https://openalex.org/W2058182256","https://openalex.org/W2150548551","https://openalex.org/W2777478371","https://openalex.org/W2937823726","https://openalex.org/W3112064419","https://openalex.org/W3119553910","https://openalex.org/W3119664087","https://openalex.org/W4362543559","https://openalex.org/W4362596092","https://openalex.org/W4386788919"],"related_works":["https://openalex.org/W2957400139","https://openalex.org/W4408663059","https://openalex.org/W2082502327","https://openalex.org/W4205513041","https://openalex.org/W2039220241","https://openalex.org/W4362543559","https://openalex.org/W1971730330","https://openalex.org/W2166670383","https://openalex.org/W2020745511","https://openalex.org/W4402069556"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-05-17T00:00:00"}